| Patent Number |
Title Of Patent |
Date Issued |
| 6747034 |
CRF receptor antagonists and methods relating thereto |
June 8, 2004 |
| CRF receptor antagonists are disclosed which have utility in the treatment of a variety of disorders, including the treatment of disorders manifesting hypersecretion of CRF in a warm-blooded animals, such as stroke. |
| 6723721 |
CRF receptor antagonists and methods relating thereto |
April 20, 2004 |
| Compounds are disclosed which have utility in the treatment of a variety of disorders, including the treatment of disorders manifesting hypersecretion of CRF in a warm-blooded animals, including stroke. The compounds of this invention have the following structures: ##STR1##wherein n, |
| 6610678 |
CRF antagonistic quino-and quinazolines |
August 26, 2003 |
| This invention concerns compounds of formula ##STR1##including the stereoisomers and the pharmaceutically acceptable acid addition salt forms thereof, wherein R.sup.1 is C.sub.1-6 alkyl, NR.sup.6 R.sup.7, OR.sup.6 or SR.sup.7 ; R.sup.2 is hydrogen, C.sub.1-6 alkyl, C.sub.1-6 alkyloxy |
| 6583143 |
CRF receptor antagonists and methods relating thereto |
June 24, 2003 |
| CRF receptor antagonists are disclosed which have utility in the treatment of a variety of disorders, including the treatment of disorders manifesting hypersecretion of CRF in a warm-blooded animals, such as stroke. The CRF receptor antagonists of this invention have the following st |
| 6541469 |
CRF receptor antagonists and methods relating thereto |
April 1, 2003 |
| CRF receptor antagonists are disclosed which have utility in the treatment of a variety of disorders, including the treatment of disorders manifesting hypersecretion of CRF in a warm-blooded animals, such as stroke. The CRF receptor antagonists of this invention have the following st |
| 6531475 |
CRF receptor antagonists and methods relating thereto |
March 11, 2003 |
| CRF receptor antagonists are disclosed which have utility in the treatment of a variety of disorders, including the treatment of disorders manifesting hypersecretion of CRF in a warm-blooded animals, such as stroke. The CRF receptor antagonists of this invention have the following st |
| 6514982 |
CRF receptor antagonists and methods relating thereto |
February 4, 2003 |
| CRF receptor antagonists are disclosed which have utility in the treatment of a variety of disorders, including the treatment of disorders manifesting hypersecretion of CRF in a warm-blooded animals, such as stroke. The CRF receptor antagonists of this invention have the following st |
| 6500839 |
CRF receptor antagonists and methods relating thereto |
December 31, 2002 |
| CRF receptor antagonists are disclosed which have utility in the treatment of a variety of disorders, including the treatment of disorders manifesting hypersecretion of CRF in a warm-blooded animals, such as stroke. The CRF receptor antagonists of this invention have the following st |
| 6482836 |
CRF antagonistic quino- and quinazolines |
November 19, 2002 |
| This invention concerns compounds of formula ##STR1##including the stereoisomers and the pharmaceutically acceptable acid addition salt forms thereof, wherein R.sup.1 is C.sub.1-6 alkyl, NR.sup.6 R.sup.7, OR.sup.6 or SR.sup.7 ; R.sup.2 is hydrogen, C.sub.1-6 alkyl, C.sub.1-6 alkyloxy |
| 6440960 |
CRF receptor antagonists and methods relating thereto |
August 27, 2002 |
| CRF receptor antagonists are disclosed which have utility in the treatment of a variety of disorders, including the treatment of disorders manifesting hypersecretion of CRF in a warm-blooded animals, such as stroke. The CRF receptor antagonists of this invention have the following st |
| 6348466 |
CRF receptor antagonists and methods relating thereto |
February 19, 2002 |
| Compounds are disclosed which have utility in the treatment of a variety of disorders, including the treatment of disorders manifesting hypersecretion of CRF in a warm-blooded animals, including stroke. The compounds of this invention have the following structures: ##STR1##wherein n, |
